- Title
- A provisional evaluation of Australia's medical cannabis program
- Creator
- Graham, Myfanwy; Chiu, Vivian; Stjepanović, Daniel; Hall, Wayne
- Relation
- International Journal of Drug Policy Vol. 122, Issue December 2023, no. 104210
- Publisher Link
- http://dx.doi.org/10.1016/j.drugpo.2023.104210
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2023
- Description
- In 2016, the Australian Government legislated to allow cannabis to be prescribed to patients as an unapproved medicine under the special access provisions of the Therapeutic Goods Act. This paper compares the Australian regulatory approach with other national approaches, outlines the main provisions of the Special Access Scheme for medical cannabis, describes how the program has evolved since 2017, includes an analysis of adverse events reported to the Therapeutic Goods Administration, and discusses the barriers that remain for patients who wish to access medical cannabis. It assesses how well the Australian program has addressed the challenges of providing patients with easier access to medical cannabis while ensuring that high-quality products are used safely and effectively under medical guidance.
- Subject
- medical cannabis; special access scheme; health policy; medicines regulation; adverse events
- Identifier
- http://hdl.handle.net/1959.13/1491368
- Identifier
- uon:53150
- Identifier
- ISSN:0955-3959
- Rights
- © 2023 The Authors. Published by Elsevier B.V. This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Language
- eng
- Full Text
- Reviewed
- Hits: 1420
- Visitors: 1432
- Downloads: 17
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 1 MB | Adobe Acrobat PDF | View Details Download |